Testosterone Transdermal System
2001134 and Yr 2-4 OL
Phase 3 small_molecule completed
Quick answer
Testosterone Transdermal System for Hypoactive Sexual Desire Disorder is a Phase 3 program (small_molecule) at Warner Chilcott Deutschland GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Warner Chilcott Deutschland GmbH
- Indication
- Hypoactive Sexual Desire Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed